Sign in
CT Perfusion as an Imaging Biomarker in Monitoring Response to Neoadjuvant Bevacizumab and Radiation in Soft-Tissue Sarcomas: Comparison With Tumor Morphology, Circulating and Tumor Biomarkers, and Gene Expression
Journal article   Open access  Peer reviewed

CT Perfusion as an Imaging Biomarker in Monitoring Response to Neoadjuvant Bevacizumab and Radiation in Soft-Tissue Sarcomas: Comparison With Tumor Morphology, Circulating and Tumor Biomarkers, and Gene Expression

Avinash Kambadakone, Sam S Yoon, Tae-Min Kim, Daniel L Karl, Dan G Duda, Thomas F DeLaney and Dushyant V Sahani
American journal of roentgenology (1976), Vol.204(1), pp.W11-W18
2015-01
PMCID: PMC4479405
PMID: 25539263

Abstract

bevacizumab CT perfusion soft-tissue sarcoma radiation therapy
url
https://doi.org/10.2214/AJR.13.12412View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.118 Soft Tissue, Bone & Nerve Cancers
1.118.300 Rhabdomyosarcoma
Web Of Science research areas
Radiology, Nuclear Medicine & Medical Imaging
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details